Special Offer



 For a special limited time:


 Get all 3:

      currinTechnology

        rick'sResearch
  
     
currinBiotech.com
                      
      
         
  for one low price.

                Learn more

With prime investment theses intact… we’re sticking with these 2017 winners

publication date: Nov 3, 2017
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
With gains of 46%, 68%, 36% and 47% respectively these four portfolio stocks have delivered very nicely in 2017.  Let’s take a brief look at each and the reason we are still quite bullish on each.  Understanding the key thesis on stocks is often the key to avoiding the noise surrounding some names.  As these companies validate the key theses in quarterly results (including growth and profits) we tend to sleep well with these names.


Sorry this page is available to premium members only.
If you're not a premium member why not join today?

If you are already a premium member, please login.

 

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content click here to become a premium member.

You will be given access to premium content on the site.